pISSN 2636-0004
eISSN 2636-0012

Table. 1.

Summary of Patient Backgrounds and Outcomes

Patient no./age (yr)/sex Etiology of liver cirrhosis Drainage route Approach route Endoscopic
treatment
No. of collaterals embolized with coils No. of EOI injections Total dose of EOI (mL) Duration of EOI injections (min) Outcomes Follow-up period (mo)
1/75/Female SBC RGV RIJV None 4 3 18 107 Not thrombosed 32
2/67/Male HCV LGV RIJV None 1 3 12.5 103 Thrombosed 28
3/76/Male Alcohol RGV RFV None 2 3 10.5 105 Thrombosed 4
4/60/Male* Alcohol RGV RFV Clipping 2 5 11 86 Thrombosed 12
5/80/Male* HCV RGV RFV EVL 0 4 21 118 Thrombosed 11
6/50/Female* Alcohol LGV RFV EVL 3 3 19 82 Thrombosed 10

EOI, ethanolamine oleate with iopamidol; SBC, secondary biliary cirrhosis; HCV, hepatitis C virus; RGV, right gonadal vein; LGV, left gonadal vein; RIJV, right internal jugular vein; RFV, right femoral vein; EVL, endoscopic variceal ligation.

*The patient had ruptured varices.

†The varices were thrombosed by additional BRTO performed 19 days later.

Int J Gastrointest Interv 2022;11:13~17 https://doi.org/10.18528/ijgii210026
© Int J Gastrointest Interv